EMA CHMP recommends approval of AMAG’s ferumoxytol: AMAG Pharmaceuticals, Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for the approval of ferumoxytol, an intravenous (IV) iron therapy, for the treatment of iron deficiency anemia (IDA) in adult patients with chronic kidney disease.
More info on Ferumoxytol : http://www.druginformation.com/RxDrugs/F/Ferumoxytol%20Injection.html
No comments:
Post a Comment